{"count": 115, "results": [{"_id": "34587943", "pmid": 34587943, "pmcid": "PMC8482657", "title": "Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction", "journal": "Lipids Health Dis", "authors": ["Pinto LCS", "Mello APQ", "Izar MCO", "Damasceno NRT", "Neto AMF", "França CN", "Caixeta A", "Bianco HT", "Póvoa RMS", "Moreira FT", "Bacchin ASF", "Fonseca FA"], "date": "2021-09-29T00:00:00Z", "doi": "10.1186/s12944-021-01559-w", "meta_date_publication": "2021 Sep 29", "meta_volume": "20", "meta_issue": "1", "meta_pages": "124", "score": 50258.832, "text_hl": "@SPECIES_9606 @@@Patients@@@ of both sexes admitted with their first @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and submitted to pharmacoinvasive strategy (N = 101) were included and randomized using a central computerized system to receive a daily dose of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg plus @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 20 mg for 30 days. ", "citations": {"NLM": "Pinto LCS, Mello APQ, Izar MCO, Damasceno NRT, Neto AMF, França CN, Caixeta A, Bianco HT, Póvoa RMS, Moreira FT, Bacchin ASF, Fonseca FA. Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction Lipids Health Dis. 2021 Sep 29;20(1):124. PMID: 34587943", "BibTeX": "@article{34587943, title={Main differences between two highly effective lipid-lowering therapies in subclasses of lipoproteins in patients with acute myocardial infarction}, author={Pinto LCS and Mello APQ and Izar MCO and Damasceno NRT and Neto AMF and França CN and Caixeta A and Bianco HT and Póvoa RMS and Moreira FT and Bacchin ASF and Fonseca FA}, journal={Lipids Health Dis}, volume={20}, number={1}, pages={124}}"}}, {"_id": "36970211", "pmid": 36970211, "pmcid": "PMC10031343", "title": "Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms", "journal": "Acta Pharm Sin B", "authors": ["Yang Y", "Feng K", "Yuan L", "Liu Y", "Zhang M", "Guo K", "Yin Z", "Wang W", "Zhou S", "Sun H", "Yan K", "Yan X", "Wang X", "Duan Y", "Hu Y", "Han J"], "date": "2023-03-01T00:00:00Z", "doi": "10.1016/j.apsb.2022.11.012", "meta_date_publication": "2023 Mar", "meta_volume": "13", "meta_issue": "3", "meta_pages": "1036-1052", "score": 50255.81, "text_hl": "Compound @CHEMICAL_danshen_dripping_pill @CHEMICAL_MESH:C000604051 @@@Danshen Dripping Pill@@@ (CDDP) or CDDP combined with @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ has been widely used to treat @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ and other @DISEASE_Cardiovascular_Diseases @DISEASE_MESH:D002318 @@@cardiovascular diseases@@@ in China. ", "citations": {"NLM": "Yang Y, Feng K, Yuan L, Liu Y, Zhang M, Guo K, Yin Z, Wang W, Zhou S, Sun H, Yan K, Yan X, Wang X, Duan Y, Hu Y, Han J. Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms Acta Pharm Sin B. 2023 Mar;13(3):1036-1052. PMID: 36970211", "BibTeX": "@article{36970211, title={Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms}, author={Yang Y and Feng K and Yuan L and Liu Y and Zhang M and Guo K and Yin Z and Wang W and Zhou S and Sun H and Yan K and Yan X and Wang X and Duan Y and Hu Y and Han J}, journal={Acta Pharm Sin B}, volume={13}, number={3}, pages={1036-1052}}"}}, {"_id": "32142170", "pmid": 32142170, "title": "Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).", "journal": "Drug Dev Res", "authors": ["He W", "Cao M", "Li Z"], "date": "2020-08-01T00:00:00Z", "doi": "10.1002/ddr.21651", "meta_date_publication": "2020 Aug", "meta_volume": "81", "meta_issue": "5", "meta_pages": "551-556", "score": 50255.09, "text_hl": "Effects of different doses of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, and @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on elderly @SPECIES_9606 @@@patients@@@ with ST-elevation @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@ (@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@AMI@@@) after percutaneous coronary intervention (PCI).", "citations": {"NLM": "He W, Cao M, Li Z. Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI). Drug Dev Res. 2020 Aug;81(5):551-556. PMID: 32142170", "BibTeX": "@article{32142170, title={Effects of different doses of atorvastatin, rosuvastatin, and simvastatin on elderly patients with ST-elevation acute myocardial infarction (AMI) after percutaneous coronary intervention (PCI).}, author={He W and Cao M and Li Z}, journal={Drug Dev Res}, volume={81}, number={5}, pages={551-556}}"}}, {"_id": "39894308", "pmid": 39894308, "title": "Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis.", "journal": "Biochem Pharmacol", "authors": ["Marunouchi T", "Matsumura K", "Sato K", "Takeuchi S", "Murakami T", "Tanonaka K"], "date": "2025-01-31T00:00:00Z", "doi": "10.1016/j.bcp.2025.116792", "meta_date_publication": "2025 Jan 31", "meta_volume": "233", "meta_issue": "", "meta_pages": "116792", "score": 50252.293, "text_hl": "Administration of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ or @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ reduced @DISEASE_Heart_Diseases @DISEASE_MESH:D006331 @@@cardiac dysfunction@@@ after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@. ", "citations": {"NLM": "Marunouchi T, Matsumura K, Sato K, Takeuchi S, Murakami T, Tanonaka K. Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis. Biochem Pharmacol. 2025 Jan 31;233():116792. PMID: 39894308", "BibTeX": "@article{39894308, title={Simvastatin and rosuvastatin attenuate necroptosis in rat failing hearts following myocardial infarction; the contribution of Hsp90 inhibition in cardiomyocytes to prevent necroptosis.}, author={Marunouchi T and Matsumura K and Sato K and Takeuchi S and Murakami T and Tanonaka K}, journal={Biochem Pharmacol}, volume={233}, pages={116792}}"}}, {"_id": "37522226", "pmid": 37522226, "title": "Persistence of a proinflammatory status after treatment of the acute myocardial infarction.", "journal": "Geriatr Gerontol Int", "authors": ["da Silva LS", "Germano DB", "Fonseca FAH", "Shio MT", "da Silva Nali LH", "Tuleta ID", "Juliano Y", "de Oliveira Izar MC", "Ribeiro AP", "Kato JT", "do Amaral JB", "França CN"], "date": "2023-07-31T00:00:00Z", "doi": "10.1111/ggi.14649", "meta_date_publication": "2023 Jul 31", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50248.18, "text_hl": "Persistence of a proinflammatory status after treatment of the @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@.", "citations": {"NLM": "da Silva LS, Germano DB, Fonseca FAH, Shio MT, da Silva Nali LH, Tuleta ID, Juliano Y, de Oliveira Izar MC, Ribeiro AP, Kato JT, do Amaral JB, França CN. Persistence of a proinflammatory status after treatment of the acute myocardial infarction. Geriatr Gerontol Int. 2023 Jul 31;():. PMID: 37522226", "BibTeX": "@article{37522226, title={Persistence of a proinflammatory status after treatment of the acute myocardial infarction.}, author={da Silva LS and Germano DB and Fonseca FAH and Shio MT and da Silva Nali LH and Tuleta ID and Juliano Y and de Oliveira Izar MC and Ribeiro AP and Kato JT and do Amaral JB and França CN}, journal={Geriatr Gerontol Int}}"}}, {"_id": "36741809", "pmid": 36741809, "pmcid": "PMC9895791", "title": "Monocytes presenting a pro-inflammatory profile persist in patients submitted to a long-term pharmacological treatment after acute myocardial infarction", "journal": "Front Physiol", "authors": ["de Carvalho DC", "Fonseca FAH", "Izar MCO", "Silveira ALPA", "Tuleta ID", "do Amaral JB", "Neves LM", "Bachi ALL", "França CN"], "date": "2023-01-20T00:00:00Z", "doi": "10.3389/fphys.2022.1056466", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "1056466", "score": 50244.18, "text_hl": "Before the invasive procedure, they were randomized using a central computerized system (battle-ami.huhsp.org.br) in a 2x2 factorial design to be treated with @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@ 20 mg or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ 40 mg plus @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ 10 mg, as well as @CHEMICAL_Ticagrelor @CHEMICAL_MESH:D000077486 @@@ticagrelor@@@ 90 mg or @CHEMICAL_Clopidogrel @CHEMICAL_MESH:D000077144 @@@clopidogrel@@@ 75 mg, in addition to routine therapy for @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@AMI@@@. ", "citations": {"NLM": "de Carvalho DC, Fonseca FAH, Izar MCO, Silveira ALPA, Tuleta ID, do Amaral JB, Neves LM, Bachi ALL, França CN. Monocytes presenting a pro-inflammatory profile persist in patients submitted to a long-term pharmacological treatment after acute myocardial infarction Front Physiol. 2022;13():1056466. PMID: 36741809", "BibTeX": "@article{36741809, title={Monocytes presenting a pro-inflammatory profile persist in patients submitted to a long-term pharmacological treatment after acute myocardial infarction}, author={de Carvalho DC and Fonseca FAH and Izar MCO and Silveira ALPA and Tuleta ID and do Amaral JB and Neves LM and Bachi ALL and França CN}, journal={Front Physiol}, volume={13}, pages={1056466}}"}}, {"_id": "36915729", "pmid": 36915729, "title": "A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction.", "journal": "Am J Transl Res", "authors": ["Yu C", "Zhang F", "Zhang L", "Li J", "Tang S", "Li X", "Peng M", "Zhao Q", "Zhu X"], "date": "2023-02-15T00:00:00Z", "meta_date_publication": "2023", "meta_volume": "15", "meta_issue": "2", "meta_pages": "932-948", "score": 50241.934, "text_hl": "This study investigated the pathogenesis of @DISEASE_Depressive_Disorder_Major @DISEASE_MESH:D003865 @@@major depressive disorder@@@ (@DISEASE_Depressive_Disorder_Major @DISEASE_MESH:D003865 @@@MDD@@@) and @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@acute myocardial infarction@@@ (@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@AMI@@@) using bioinformatics. ", "citations": {"NLM": "Yu C, Zhang F, Zhang L, Li J, Tang S, Li X, Peng M, Zhao Q, Zhu X. A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction. Am J Transl Res. 2023;15(2):932-948. PMID: 36915729", "BibTeX": "@article{36915729, title={A bioinformatics approach to identifying the biomarkers and pathogenesis of major depressive disorder combined with acute myocardial infarction.}, author={Yu C and Zhang F and Zhang L and Li J and Tang S and Li X and Peng M and Zhao Q and Zhu X}, journal={Am J Transl Res}, volume={15}, number={2}, pages={932-948}}"}}, {"_id": "33185670", "pmid": 33185670, "title": "Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.", "journal": "JAMA Cardiol", "authors": ["Marcusa DP", "Giugliano RP", "Park JG", "de Lemos JA", "Cannon CP", "Sabatine MS"], "date": "2020-11-13T00:00:00Z", "doi": "10.1001/jamacardio.2020.6184", "meta_date_publication": "2020 Nov 13", "meta_volume": "6", "meta_issue": "5", "meta_pages": "1-5", "score": 50238.18, "text_hl": "DESIGN, SETTING, AND PARTICIPANTS: This secondary exploratory study analyzed data from 3 randomized placebo-controlled clinical trials (Aggrastat to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Zocor@@@-@<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@Thrombolysis in Myocardial Infarction 21@@@ [A to Z-TIMI 21], Improved Reduction of Outcomes: Vytorin Efficacy International Trial [IMPROVE-IT], and Further Cardiovascular Outcomes Research With @GENE_PCSK9 @GENE_255738 @@@PCSK9@@@ Inhibition in Subjects With Elevated Risk [FOURIER]) of @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-lowering therapies (statin, @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@, and a @GENE_PCSK9 @GENE_255738 @@@PCSK9@@@ inhibitor) and included participants with @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerotic cardiovascular disease@@@. ", "citations": {"NLM": "Marcusa DP, Giugliano RP, Park JG, de Lemos JA, Cannon CP, Sabatine MS. Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition. JAMA Cardiol. 2020 Nov 13;6(5):1-5. PMID: 33185670", "BibTeX": "@article{33185670, title={Association of Baseline Low-Density Lipoprotein Cholesterol and Percentage Low-Density Lipoprotein Cholesterol Reduction With Statins, Ezetimibe, and PCSK9 Inhibition.}, author={Marcusa DP and Giugliano RP and Park JG and de Lemos JA and Cannon CP and Sabatine MS}, journal={JAMA Cardiol}, volume={6}, number={5}, pages={1-5}}"}}, {"_id": "34910821", "pmid": 34910821, "title": "Psychological and pharmacological interventions for depression in patients with coronary artery disease.", "journal": "Cochrane Database Syst Rev", "authors": ["Tully PJ", "Ang SY", "Lee EJ", "Bendig E", "Bauereiß N", "Bengel J", "Baumeister H"], "date": "2021-12-15T00:00:00Z", "doi": "10.1002/14651858.CD008012.pub4", "meta_date_publication": "2021 Dec 15", "meta_volume": "12", "meta_issue": "12", "meta_pages": "CD008012", "score": 50217.883, "text_hl": "The evidence was very uncertain for end-of-treatment effects on all-cause mortality, and data were not reported for end-of-treatment cardiovascular mortality and occurrence of @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarction@@@ for this comparison. ", "citations": {"NLM": "Tully PJ, Ang SY, Lee EJ, Bendig E, Bauereiß N, Bengel J, Baumeister H. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. PMID: 34910821", "BibTeX": "@article{34910821, title={Psychological and pharmacological interventions for depression in patients with coronary artery disease.}, author={Tully PJ and Ang SY and Lee EJ and Bendig E and Bauereiß N and Bengel J and Baumeister H}, journal={Cochrane Database Syst Rev}, volume={12}, number={12}, pages={CD008012}}"}}, {"_id": "11349324", "pmid": 11349324, "title": "[Simvastatin after myocardial infarct. Losing no time].", "journal": "MMW Fortschr Med", "date": "2001-04-12T00:00:00Z", "meta_date_publication": "2001 Apr 12", "meta_volume": "143", "meta_issue": "15", "meta_pages": "51", "score": 50076.68, "text_hl": "[@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ after @<m>DISEASE_Myocardial_Infarction</m> @DISEASE_MESH:D009203 @@@myocardial infarct@@@. ", "citations": {"NLM": "[Simvastatin after myocardial infarct. Losing no time]. MMW Fortschr Med. 2001 Apr 12;143(15):51. PMID: 11349324", "BibTeX": "@article{11349324, title={[Simvastatin after myocardial infarct. Losing no time].}, journal={MMW Fortschr Med}, volume={143}, number={15}, pages={51}}"}}]}